A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report

Colorectal cancer (CRC) is one of the most common cancer types around the world. The prognosis of patients with advanced diseases is still poor in spite of currently available therapeutic options. Regorafenib is an oral tyrosine kinase inhibitor (TKI) approved to treat refractory metastatic colorect...

Descripción completa

Detalles Bibliográficos
Autores principales: De Summa, Simona, Danza, Katia, Pilato, Brunella, Matera, Giuseppina, Fasano, Rossella, Calabrese, Angela, Lacalamita, Rosanna, Silvestris, Nicola, Tommasi, Stefania, Argentiero, Antonella, Brunetti, Oronzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619854/
https://www.ncbi.nlm.nih.gov/pubmed/34833459
http://dx.doi.org/10.3390/medicina57111241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619854/
https://www.ncbi.nlm.nih.gov/pubmed/34833459
http://dx.doi.org/10.3390/medicina57111241

Ejemplares similares